The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Aerscher Diagnostics sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Aerscher Diagnostics is a medical device company. The company designs, manufactures and markets point-of-care occult blood testing products. It produces guaiac-based occult blood testing products. Aerscher’s products include hemaprompt FG and hemaprompt. It specializes in the manufacturing of guaiac-based occult blood testing products. The company sells its products to various small hospitals, clinics, and teaching hospitals. It markets its products through a network of distributors throughout the country. Aerscher is headquartered in Chestertown, Maryland, the US.
The key metrics of Aerscher Diagnostics related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Aerscher Diagnostics is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Aerscher Diagnostics.
For a detailed understanding of the performance of Aerscher Diagnostics, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.